- Home
- OLMA vs PAYS Comparison
OLMA vs PAYS Comparison
Compare OLMA & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLMA | PAYS |
|---|---|---|
| Founded | 2006 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 725.5M | 293.4M |
| IPO Year | 2020 | 1998 |
Fundamental Metrics
Financial Performance| Metric | OLMA | PAYS |
|---|---|---|
| Price | $35.48 | $5.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $40.50 | $8.06 |
| AVG Volume (30 Days) | ★ 8.5M | 372.6K |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.13 |
| Revenue | N/A | ★ $74,879,428.00 |
| Revenue This Year | N/A | $41.20 |
| Revenue Next Year | N/A | $20.62 |
| P/E Ratio | ★ N/A | $42.18 |
| Revenue Growth | N/A | ★ 32.61 |
| 52 Week Low | $2.86 | $1.80 |
| 52 Week High | $33.50 | $8.88 |
Technical Indicators
Market Signals| Indicator | OLMA | PAYS |
|---|---|---|
| Relative Strength Index (RSI) | 85.25 | 52.34 |
| Support Level | $25.62 | $5.11 |
| Resistance Level | $33.50 | $5.60 |
| Average True Range (ATR) | 2.33 | 0.19 |
| MACD | 0.42 | 0.05 |
| Stochastic Oscillator | 95.78 | 60.00 |
Price Performance
Historical ComparisonAbout OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.